HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog IndustryEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed……Please subscribe to read the full story.Author admin View all posts Post navigationPrevious PostMitsubishi Chemical to Mass-Produce GaN Substrates for More Energy-Efficient Vehicles, Devices Next PostJSR to Boost Production Capacity for Advanced Semiconductor PhotoresistsYou Might Also Like BlogHazardous Chemical Substances: Understanding Risks and Safety Measures admin September 18, 2023 BlogKawasaki Leads Japan’s Push for Industrial Complexes With Hydrogen Energy, Carbon Recycling admin August 14, 2023 BlogBOPP Film Meets With Rising Demand for Use in Automotive Film Capacitors admin August 14, 2023 BlogDIC Targets Bio-SAP Market With Polyaspartic Acid admin August 14, 2023
BlogKawasaki Leads Japan’s Push for Industrial Complexes With Hydrogen Energy, Carbon Recycling admin August 14, 2023